ProCE Banner Activity

Chronic Myeloid Leukemia Interactive Decision Support Tool: Expert Guidance on Monitoring Response to BCR-ABL1 Inhibitors in CML


Use this Interactive Decision Support Tool to compare your management of patients with CML with those of 5 renowned CML experts.

Released: March 30, 2022

Expiration: March 29, 2023

No longer available for credit.
Begin Activity



Jorge Cortes

Jorge Cortes, MD

Professor of Medicine
Deputy Chair, Department of Leukemia
M.D. Anderson Cancer Center
Houston, Texas

Daniel J. DeAngelo

Daniel J. DeAngelo, MD, PhD

Associate Professor of Medicine
Department of Medicine
Harvard Medical School
Clinical Director, Adult Leukemia Program
Department of Medical Oncology
Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Boston, Massachusetts

Smith B Douglas

Smith B Douglas,

Michael J. Mauro

Michael J. Mauro, MD

Associate Professor
Knight Cancer Institute, Center for Hematologic Malignancies
Oregon Health and Science University
Portland, Oregon

Neil P. Shah

Neil P. Shah, MD, PhD

Assistant Professor
Division of Hematology/Oncology
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from

Novartis Pharmaceuticals Corporation

Pfizer, Inc.

Additional Information

Program Medium

This program has been made available online.